Household income

6 papers7 findings

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

On aging: the drug’s trials ARN judged to be about aging, of every trial that tests it for any use.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

5 independent labs in 2 countries

Funders: Canadian Institutes of Health Research and 4 more

Humans6

Outcomes

PhenoAgeAccel

downin silico1

1 study

Household income decreases PhenoAgeAccel in silico (β = -1.72; 95% CI: -2.28, -1.15).
“household income (β = -1.72; 95% CI: -2.28, -1.15), and occupational attainment (β = -0.50; 95% CI: -0.79, -0.22) were inversely associated with PhenoAgeAccel”
In silico
Genetic insights into socioeconomic inequalities and adiposity-related interventions for reducing accelerated biological aging
International journal of obesity (2005)10 Feb 2026

Associations

Multimorbidity

downin humans1

1 study

Household income lowers the risk of multimorbidity in humans (IRR=0.66, 95% CI: 0.46-0.96, p = 0.031).
“Middle-income men had lower MM (IRR=0.66, 95% CI: 0.46-0.96, p = 0.031)”
Humansmales
SES and Multimorbidity Among Black Women and Men: A Case of Diminishing Returns?
GSA 2025 abstract31 Dec 2025